This BSL-4 core provides the infrastructure to permit safe work to be performed on aerosol-infectious,potentially lethal agents. It consists of the mechanical safeguards of two high-containment laboratories,the provision of training in BSL-4 operations, and assistance in operations within the laboratories. Generally,the investigators will work within the laboratory, but about 20% of the effort will be devoted to challengeexperiments using established animal models to test newly developed vaccines and therapeutics. Part ofthis core is located at Southwest Foundation for Biomedical Research (SF BR) in San Antonio, TX where1200 ft 2 of BSL-4 laboratory space is available. The other component is scheduled for completion in June,2003 and will provide 2000 ft 2 at the University of Texas Medical Branch, Galveston, TX. The SFBR facilityhas been in operation since March of 2000 and provides space for microbiological operations as well ashousing for rodents and small non-human primates. UTMB will have 1000 ft 2devoted primarily to animalsand 1000 ft 2 mainly used to for microbiology. Both have access to a high intensity gamma irradiator allowinginactivation of samples for further analysis outside the BSL-4 laboratory. This core is essential for work onthe hemorrhagic fever viruses and multidrug resistant highly pathogenic bacteria.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
3U54AI057156-05S1
Application #
7649747
Study Section
Special Emphasis Panel (ZAI1-KLW-M (M3))
Project Start
2008-03-01
Project End
2009-02-28
Budget Start
2008-03-01
Budget End
2009-02-28
Support Year
5
Fiscal Year
2008
Total Cost
$191,010
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Pandey, Aseem; Lin, Furong; Cabello, Ana L et al. (2018) Activation of Host IRE1?-Dependent Signaling Axis Contributes the Intracellular Parasitism of Brucella melitensis. Front Cell Infect Microbiol 8:103
Russell-Lodrigue, Kasi E; Killeen, Stephanie Z; Ficht, Thomas A et al. (2018) Mucosal bacterial dissemination in a rhesus macaque model of experimental brucellosis. J Med Primatol 47:75-77
Matz, L M; Kamdar, K Y; Holder, M E et al. (2018) Challenges of Francisella classification exemplified by an atypical clinical isolate. Diagn Microbiol Infect Dis 90:241-247
Langsjoen, Rose M; Haller, Sherry L; Roy, Chad J et al. (2018) Chikungunya Virus Strains Show Lineage-Specific Variations in Virulence and Cross-Protective Ability in Murine and Nonhuman Primate Models. MBio 9:
Raja, B; Goux, H J; Marapadaga, A et al. (2017) Development of a panel of recombinase polymerase amplification assays for detection of common bacterial urinary tract infection pathogens. J Appl Microbiol 123:544-555
Nunes, Marcio R T; Contreras-Gutierrez, María Angélica; Guzman, Hilda et al. (2017) Genetic characterization, molecular epidemiology, and phylogenetic relationships of insect-specific viruses in the taxon Negevirus. Virology 504:152-167
Rossetti, Carlos A; Drake, Kenneth L; Lawhon, Sara D et al. (2017) Systems Biology Analysis of Temporal In vivo Brucella melitensis and Bovine Transcriptomes Predicts host:Pathogen Protein-Protein Interactions. Front Microbiol 8:1275
Paterson, Andrew S; Raja, Balakrishnan; Mandadi, Vinay et al. (2017) A low-cost smartphone-based platform for highly sensitive point-of-care testing with persistent luminescent phosphors. Lab Chip 17:1051-1059
Park, Arnold; Yun, Tatyana; Hill, Terence E et al. (2016) Optimized P2A for reporter gene insertion into Nipah virus results in efficient ribosomal skipping and wild-type lethality. J Gen Virol 97:839-43
Inglis, Fiona M; Lee, Kim M; Chiu, Kevin B et al. (2016) Neuropathogenesis of Chikungunya infection: astrogliosis and innate immune activation. J Neurovirol 22:140-8

Showing the most recent 10 out of 384 publications